Stock Yards Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-3,390
Closed -$313K – 378
2024
Q2
$313K Hold
3,390
– – 0.01% 319
2024
Q1
$324K Hold
3,390
– – 0.01% 324
2023
Q4
$258K Sell
3,390
-687
-17% -$47.8K 0.01% 342
2023
Q3
$282K Sell
4,077
-294
-7% -$23.6K 0.01% 330
2023
Q2
$412K Buy
4,371
+294
+7% +$25.6K 0.02% 303
2023
Q1
$337K Buy
4,077
+155
+4% +$12.2K 0.01% 323
2022
Q4
$293K Hold
3,922
– – 0.01% 350
2022
Q3
$324K Hold
3,922
– – 0.01% 329
2022
Q2
$373K Buy
+3,922
New +$406K 0.02% 324

Other funds holding EW

Stock Yards Bank & Trust's EW Position: Q3 2024 in Review

Stock Yards Bank & Trust sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 3,390 shares — an estimated $313K sold.

Stock Yards Bank & Trust first reported a position in EW in Q2 2022 and held it in 9 quarters. The position peaked at $412K in Q2 2023. 1,195 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Stock Yards Bank & Trust reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Stock Yards Bank & Trust sold 3,390 Edwards Lifesciences shares in Q3 2024, an estimated $313K.
  • Stock Yards Bank & Trust first reported a position in Edwards Lifesciences in Q2 2022 and held it in 9 quarters.
  • Stock Yards Bank & Trust's Edwards Lifesciences position peaked at $412K in Q2 2023.
  • 1,195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Stock Yards Bank & Trust's 13F filing for Q3 2024, filed 22 Nov 2024.